355. Claudia Nari on Inari’s unique advantage + gene editing as a new paradigm in agbioscience

Agbioscience

Content provided by AgriNovus Indiana. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by AgriNovus Indiana or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

2M ago 18:06

MP3•Episode home

Fetch error

Hmmm there seems to be a problem fetching this series right now. Last successful fetch was on June 02, 2025 09:40 (4d ago)

What now? This series will be checked again in the next day. If you believe it should be working, please verify the publisher's feed link below is valid and includes actual episode links. You can contact support to request the feed be immediately fetched.

Gene editing in plants – it's been heralded as the next step-function change in the advancement of agriculture. One Indiana company is advancing the technology fresh off a $144 million venture capital raise. Claudia Nari, Chief Product Officer of Inari, joins today to talk through this historic time for gene editing and biotechnology at large. They get into:

From speed to precision, Claudia lays out the differentiation of gene editing to other types of plant breeding
Crops of focus for Inari right now and stresses they’re focused on to enable farmer success
The company’s recent venture capital raise, their value proposition and educating investors
Inari’s unique advantage (knowing what to do, having the tools to do it and being able to do those at the same time)
The status of field trials and what commercialization will look like for Inari
Biggest problems in-field to be solved through gene editing – from yield to resource efficiencies
Regulatory hurdles and Claudia’s perspective on the acceptance of gene editing as a technology
When will Inari technology be in customer fields? And what’s next?

366 episodes